Name: Allarity Therapeutics, Inc. (ALLR) Financial Statements
Creator: FinSpry

Allarity Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Allarity Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	6.10	7.10	7.64	14.20	4.22
Selling, General & Administrative	11.44	10.03	9.96	12.36	4.10
Operating Expenses	17.54	17.13	16.89	26.56	8.32
Operating Income	-17.54	-17.13	-16.89	-26.56	-8.32
Other Income/Expense
Interest Income	0.53	0.02	0.03	0.00	0.00
Interest Expense	0.65	0.50	-0.22	-0.59	-0.32
Other Income/Expense	-7.24	5.79	17.13	0.35	1.56
Income
Income Before Tax	-24.90	-11.82	-17.58	-26.52	-6.42
Income Tax Expense	-0.38	0.08	-1.52	0.13	0.20
Net Income	-24.52	-11.90	-16.06	-26.65	-6.60
Net Income - Continuous Operations	-24.52	-11.90	-16.06	-26.65	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-24.23	-11.28	-16.83	-26.45	-8.27
EBIT	-24.24	-11.32	-16.89	-26.56	-8.32
Depreciation & Amortization	0.01	0.04	0.06	0.11	0.05
Earnings Per Share
Basic EPS	-16.00	-6156.00	-31799.00	-79074.00	-
Diluted EPS	-16.00	-6156.00	-31799.00	-79074.00	-
Basic Shares Outstanding	1.61	0.00	0.00	0.00	0.00
Diluted Shares Outstanding	1.61	0.00	0.00	0.00	0.00